Kevin Chapman

Celesta Global Capital Managers LLC (Celesta Capital) is a venture capital firm founded in 2013 by Michael Marks, Nicholas Brathwaite, Sriram Viswanathan and Lip-Bu Tan. The firm is headquartered in San Francisco, California.

Prellis Biologics, Inc. engages in building human tissues for drug development, and also develops human organs for transplantation. It offers vascularized tissue, bio and human organ printing. The firm's products include Organoid, Vascular Bundle, 3D Tissue Chip, Cell Seeding Matrix, Cell Adhesion Plus and Holograph-X Bioprinter. The company was founded by Noelle Huskey Mullin and Melanie Matheu in October 2016 and is headquartered in San Francisco, CA.

Pacific Bioscience Laboratories Inc. engages in the development of health and skin care products. It offers face brushes, crush heads, and face cleaners. It operates under the Clarisonic brand. The company was founded by Dr. Robert E. Akridge, David Giuliani and Kenneth A. Pilcher in 2001 and is headquartered in Bellevue, WA.

Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA.